Ranitidine Recall & Ranitidine Cancer Lawsuits
Cincinnati, Ohio Pharmaceutical Injury Attorney reviewing recent ranitidine recall lawsuits and Zantac cancer cases for plaintiffs nationwide.
In a development that has encompassed a large part of the heartburn drug market, a number of generic Zantac drugs were recalled this week. Since November 12th, four more companies have issued a ranitidine recall, due to contamination risks that have linked carcinogens to patient cancer cases. Thus far, there have been nine Ranitidine recalls.
Zantac, and its generic counterpart, ranitidine, has been prescribed millions times a year, and is available in OTC versions as well. Nobody has thought much about the safety of the medications until recently when the Food and Drug Administration (FDA) said testing showed Zantac and ranitidine contained a probable carcinogen.
The following heartburn drugs have been recalled from shelves across the U.S with fears of the contaminated drugs allegedly presenting an increased risk of cancer:
- Nov. 12: American Health Packaging recalled its 150 mg ranitidine syrup.
- Nov. 14: Amneal Pharmaceuticals recalled 150 mg and 300 mg ranitidine tablets and15 mg ranitidine syrup.
- Nov. 19: Golden State Medical Supply recalled ranitidine capsules following a manufacturer’s recall.
- Nov. 21: Precision Dose recalled ranitidine oral solution in response to Amneal’s recall.
Joe Lyon is an experienced Cincinnati, Ohio Pharmaceutical Recall Attorney reviewing drug injury cancer cases for plaintiffs nationwide. If you have been diagnosed with cancer following the use of a heartburn medication, contact The Lyon Firm for a free case review.
Ranitidine Recall & Cancer Risk
Should you stop taking ranitidine? Is Zantac dangerous? These are questions you must tackle with your personal physician. The Lyon Firm can discuss legal options with injured consumers, and can work with medical experts in help determining the root cause of your cancer.
The FDA has found unacceptable levels of a probable carcinogen, NDMA—nitrosodimethylamine—in Zantac and generic ranitidine heartburn and ulcer medications. The FDA also extended a recall for a similar drug, nizatidine, sold under the brand name Axid.
The first Zantac contamination warning came after Valisure discovered NDMA in several variations of the drug and alerted the FDA. Consumer protection lawyers are concerned the drug’s potential cancer risk could have been present since the early 1980s.
Zantac Cancer Lawsuits
Product Liability attorneys are investigating consumer class action and individual personal injury lawsuits, alleging that Sanofi and other drug companies were aware of the cancer risks that ranitidine and Zantac presented.
There are already hundreds of pending lawsuits over Zantac, which Sanofi has since recalled. Litigation is in the early stages, those who have been diagnosed with the following cancer should contact a drug injury lawyer to discuss legal action:
- Bladder cancer
- Colon cancer
- Rectal cancer
- Intestinal cancer
- Kidney cancer
- Uterine cancer
- Liver cancer
- Ovarian cancer
- Prostate cancer
- Esophageal cancer
- Stomach cancer
- Pancreatic cancer
- Testicular cancer
- Thyroid cancer
Ohio Ranitidine Recall Attorney
Studies are currently highlighting the specific mechanism in which the drug contamination causes cancer. Some experts suggest the evidence that the drugs may cause cancers in certain patients is indisputable.
Those close to the matter note that what we are seeing is not a manufacturing problem, but rather an error in how NDMA interacts with the human body. The FDA said it was investigating the presence of NDMA in ranitidine medications but did not recommend halting the use. Meanwhile, the retailers Rite Aid, CVS, Walmart and Walgreens pulled ranitidine from the shelves.
If you or a loved one has been diagnosed with cancer following the use of an ulcer or heartburn medication, and have questions about the root cause and the legal remedies available to improve quality of life and medical care in Ohio, contact The Lyon Firm at (800) 513-2403. You will speak directly with Mr. Lyon, and he will help you answer critical questions regarding the ranitidine recall.